Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Deutsche Boerse AG  >  Nestlé S.A.    NESR   CH0038863350


Delayed Quote. Delayed Deutsche Boerse AG - 06/28 01:55:19 pm
90.53 EUR   -0.08%
12/12NESTLE NIGERIA : retrieves 100m Maggi wrappers
12/12Antitrust authorities are having a field day
12/12NESTLE S A : makes strategic move to create global leader in ice cream
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Nestlé Puts Unit Under Review -- WSJ

share with twitter share with LinkedIn share with facebook
share via e-mail
09/21/2018 | 02:49am EST

By Saabira Chaudhuri and Brian Blackstone

Nestlé SA is exploring strategic options for its skin-health unit, a business analysts say could fetch $4.1 billion, its latest move to narrow its focus to food and beverages as it faces pressure from an activist investor.

The Swiss consumer goods giant Thursday didn't specifically say the unit, which generated 2017 revenue of 2.7 billion Swiss francs ($2.79 billion), was up for sale but such reviews often end with a disposal. Nestlé recently sold its U.S. confectionery and Gerber life-insurance businesses after similar reviews.

Nestlé didn't disclose an estimated value for the skin-health division, which includes face-care products Cetaphil and Proactiv, but it could fetch about 4 billion francs, according to Jefferies analyst Martin Deboo. Mr. Deboo said the review was significant because it showed a "willingness to slay sacred cows."

The move comes as Nestlé faces pressure from activist investor Daniel Loeb who took a $3.5 billion stake in the company last year and has made a string of demands, including that it sell its stake in L'Oréal SA and the skin-health arm.

The review is likely to close the door on a business that Nestlé just four years ago touted as one of its most promising. Nestlé established its skin-health unit in 2014 after taking full control of Galderma, which added acne and skin-cancer treatment to its portfolio. Nestlé said at the time it wanted to take a more holistic approach to health than "mere nutrition" and bolstered the unit with several acquisitions including a $1.4 billion deal for skin-care products from Valeant Pharmaceuticals Inc.

But as sales growth slowed, investors questioned how the unit fit into Nestlé's broader business. Nestlé had until now worked to fix problems at its skin-health business, which suffered after investing aggressively in consumer skin-care products and as patents on prescription products expired.

But Thursday, Nestlé said it had decided the unit's growth opportunities "lie increasingly outside the group's strategic scope." It expects the review to be completed by mid-2019.

Nestlé generated nearly 90 billion francs of sales last year but is shuffling its huge portfolio of products, ranging from Maggi noodles to Purina pet food and DiGiorno frozen pizza, to combat slowing growth. Chief Executive Mark Schneider had committed to shuffling 10% of Nestlé's portfolio but Thursday's announcement goes 3% above that said Mr. Deboo.

Like other consumer-goods companies, Nestlé has struggled with changing consumer tastes that favor local, organically produced food and difficulty in raising its prices amid a low-inflation environment. Mr. Schneider hopes that by narrowing its focus to fast-growing parts of its business including coffee, bottled water and pet food, he can lift sales growth, which last year weakened to its slowest pace since at least the mid-1990s.

On Monday, Nestlé said it would sell its Gerber Life Insurance unit to Western & Southern Financial Group for $1.55 billion in cash. In January, it sold its U.S. confectionery business -- which includes Butterfinger and Baby Ruth candy bars -- to Italian candy maker Ferrero International SA for $2.8 billion in cash.

Mr. Loeb, since taking his stake, has been vocal in criticizing Nestlé, noting just half its sales comes from the businesses Mr. Schneider has said are key for growth: coffee, petcare, water and infant nutrition. He said Nestlé could rid itself of frozen food, ice cream, packaged meats, pasta and peanut milk in addition to other assets.

"We expect Nestlé to further divest nonstrategic, underperforming assets," said analysts at Vontobel, in reaction to Thursday's announcement on skin health.

Meanwhile, Nestlé has made some splashy acquisitions, particularly in coffee. In May, it bought the rights to market and sell Starbucks coffee and tea products in grocery and retail stores for more than $7 billion. Last year, Nestlé bought a majority stake in U.S. premium coffee chain Blue Bottle.

Alberto Delclaux contributed to this article.

Write to Saabira Chaudhuri at saabira.chaudhuri@wsj.com and Brian Blackstone at brian.blackstone@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
CLASS III MILK FUTURES (DC) - CMG (ELECTRONIC)/C1 -0.15% 19.4 End-of-day quote.40.49%
CLASS IV MILK?FUTURES (GDK) - CMG (ELECTRONIC)/C1 0.00% 16.73 End-of-day quote.10.72%
DRY WHEY?FUTURES (DY) - CMG (ELECTRONIC)/C1 0.77% 32.75 End-of-day quote.-30.85%
FORBO HOLDING AG 2.50% 1643 Delayed Quote.16.08%
LONDON COFFEE -1.07% 1765 End-of-day quote.0.00%
LONDON SUGAR 0.77% 354.2 End-of-day quote.6.05%
NESTLÉ S.A. -0.14% 102.94 Delayed Quote.29.17%
NESTLÉ S.A. -0.08% 90.53 Delayed Quote.27.15%
NEW YORK COCOA -1.77% 2609 End-of-day quote.7.85%
NONFAT DRY MILK FUTURES (GNF) - CMG (ELECTRONIC)/C1 0.08% 120.9 End-of-day quote.33.11%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on NESTLÉ S.A.
12/12NESTLE NIGERIA : retrieves 100m Maggi wrappers
12/12Antitrust authorities are having a field day
12/12NESTLE S A : makes strategic move to create global leader in ice cream
12/12NESTLE S A : Factbox - Nestle CEO Mark Schneider's top deals over the past three..
12/12Nestlé Set to Sell Ice-Cream Unit -- WSJ
12/12NESTLE S A : to sell US ice cream business to joint venture in $4bn agreement
12/11NESTLE S A : sells U.S. ice cream brands to joint venture Froneri in $4 billion ..
12/11Nestlé to Sell U.S. Ice Cream Business to Joint Venture --Update
12/11Nestlé to Sell U.S. Ice Cream Business to Joint Venture
12/11NESTLE : Froneri JV Takes Control of US Ice-Cream Business in $4 Billion Deal
More news
Financials (CHF)
Sales 2019 93 215 M
EBIT 2019 16 458 M
Net income 2019 12 568 M
Debt 2019 27 624 M
Yield 2019 2,61%
P/E ratio 2019 24,3x
P/E ratio 2020 23,3x
EV / Sales2019 3,49x
EV / Sales2020 3,48x
Capitalization 297 B
Duration : Period :
Nestlé S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 111,65  CHF
Last Close Price 102,94  CHF
Spread / Highest target 18,5%
Spread / Average Target 8,46%
Spread / Lowest Target -14,5%
EPS Revisions
Ulf Mark Schneider Chief Executive Officer & Director
jeff hamilton President
Paul Bulcke Chairman
Magdi Batato Executive Vice President-Operations
François-Xavier Michel Marie Roger Chief Financial Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
NESTLÉ S.A.27.15%302 334
NESTLÉ S.A.29.17%302 334
DANONE19.30%52 877
GENERAL MILLS, INC.32.51%31 187